mRNA & RNA-Based Therapies
mRNA and RNA-based therapies are transforming medicine, from cancer treatment to vaccine development. Stay updated on the latest research and breakthroughs in RNA technology.
This Super Common Habit Could Be Raising Your Risk for Endometrial Cancer
Endometrial cancer isn’t talked about much as much as it should be. It’s the most common cancer of the female reproductive organs in the U.S. and more than 69,000 people in the U.S. are diagnosed with it each year.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer.
Can a popular vitamin supplement increase cancer risk?
Nicotinamide riboside (NR), a form of vitamin B3, is often promoted for its potential benefits in improving heart, metabolism, and brain health. Many people take it as a supplement to boost their energy levels and overall well-being.
Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer
The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive for grade group (GG) ≥2 prostate cancer and can improve the proportion of biopsies avoided.
100-year-old heart drug made from foxglove may help ‘dissolve’ clumps of spreading cancer cells
By breaking up clusters of cancer cells, an old heart drug called digoxin may help stop tumors from spreading to other organs, a small trial shows.
Blood Test for Early Pancreatic Cancer Shows Promise
The blood test achieved high accuracy, with 98% specificity and 73% sensitivity for detecting pancreatic cancer.
US firm brings new prostate cancer treatment to Hong Kong, cutting risks posed by surgery
An American medical technology firm has introduced a novel treatment in Hong Kong that uses electric pulses to kill prostate cancer cells while minimising the risks of incontinence and sexual dysfunction.
Efforts to improve cancer research must persist and intensify – opinion
The integration of new technologies and treatment paradigms into the country’s health system each year enhances patients’ quality of life and enables many to manage their illnesses more effectively.
Breast cancer treatment advances with light-activated ‘smart bomb’
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated metastatic breast cancer tumors.
Lilly, AdvanCell to collaborate on alpha treatments for cancer
Eli Lilly (NYSE:LLY) and AdvanCell have agreed to work together on developing alpha therapies for the treatment of cancer.
Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
Researchers have developed a new nanosystem that provides precision targeting and therapy for tongue cancer, potentially improving treatment outcomes.
Innovative Medicines
Patients with a wide range of life-threatening and debilitating illnesses today live in the hope tomorrow will bring a new medicine that will improve or even save their life. America’s biopharmaceutical research companies are researching and developing new medicines to meet unmet need and continuing research and development even after U.S. Food and Drug Administration (FDA) approval, all with the goal of improving patients’ health, quality of life, and saving lives.
